Drive payer submission readiness for your Phase 2 and 3 products
Encourage integrated decision-making between affiliate and global functions to build an evidence generation plan
Provide a systematic assessment of payer evidence readiness for your product against actual submission template requirements with a visual heatmap
Generate an organizational vision and action plan to anticipate and mitigate value challenges to optimize payer readiness
Understanding and adapting to evolving payer requirements is becoming increasingly important to managing market access risk and delivering commercial success. Rapid developments in the treatment landscape present new challenges for payers who have different perspectives on value and approaches to market access, while manufacturers are under pressure to bring products to market quickly.
PRMA Healthcheck™ - late module
- Provides a robust situational analysis based on a consistent and systemized framework that rates your current evidence generation activities against the individual requirements from payer submission templates relevant to your asset
- Presents a comprehensive summary of the evidence gaps with a red-amber-green rating of potential challenges, encouraging early clear and consistent communication across the organization
- Accelerates HTA submission readiness by producing a high-quality evidence generation plan driven by informed, collaborative, and integrated decision-making
- Identifies clear responsibilities across global, regional and affiliates for implementation, recognizing that not all gaps can or will be bridged
Our user friendly applications and expert team have supported organizations around the world in achieving their goals. We are always happy to have an informal, confidential chat and help you re-think your market access challenges.